1. Cancer & Stem Cell Biology Signature Research Programme, Duke-NUS Medical School, Singapore;
2. Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore;
3. School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China;
4. Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan;
5. Division of Hematology-Oncology, Department of Medicine, University of Alabama Birmingham, Birmingham, AL;
6. Department of Hematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore;
7. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore;
8. Cancer Science Institute of Singapore, National University of Singapore, Singapore;
9. Department of Molecular Biology & Biochemistry, University of California, Irvine, CA;
10. Computational and Systems Biology, Genome Institute of Singapore, Singapore;
11. Institute of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany;
12. Human Genetics, Genome Institute of Singapore, Singapore;
13. Next Generation Sequencing Platform, Genome Institute of Singapore, Singapore;
14. Department of Haematology, Singapore General Hospital, Singapore;
15. Department of Medical Oncology, National Cancer Centre, Singapore; and
16. Department of Medicine, Duke University Medical Center, Durham, NC